|
Vancomycin 125mg Clinical Trials
2 actively recruiting trials across 1 location
▲ +1 trial since June 2026
Pipeline
Phase 1: 1Phase 1/2: 1
Top Sponsors
- Institute of Cancer Research, United Kingdom1
- Abramson Cancer Center at Penn Medicine1
Indications
- Cancer2
- Non-Hodgkin Lymphoma (NHL)1
- Diffuse Large B Cell Lymphoma Relapsed1
- Diffuse Large B Cell Lymphoma Refractory1
- Metastatic Castration-resistant Prostate Cancer, mCRPC1
Other1 trial
Philadelphia, Pennsylvania1 trial
Radiation, Oral Vancomycin, and CAR-T for B-Cell Lymphomas
Abramson Cancer Center, University of Pennsylvania
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.